Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PMAX | Powell Max | $2.51 | -$1.47 | -36.82% | 684.5K | $4.1M | $1.90$89.60 |
| ENHA | Enhanced | $6.60 | -$3.10 | -31.96% | 109.6K | $264M | $6.49$14.00 |
| SMX | Smx (Security Matters) Public | $15.80 | -$6.40 | -28.83% | 207K | $106M | $15.25$394,297.25 |
| IONZ | Tidal Trust II - Defiance Daily Target 2x Short Ionq ETF | $3.70 | -$1.38 | -27.17% | 15.7M | - | $3.51$137.71 |
| MASK | 3 E Network Technology Group | $2.38 | -$0.80 | -25.16% | 715.5K | $3.6M | $1.19$95.75 |
| RKLZ | Tidal Trust II - Defiance Daily Target 2x Short Rklb ETF | $3.15 | -$0.91 | -22.35% | 16.1M | - | $3.02$204.07 |
| SHIM | Shimmick | $4.52 | -$1.24 | -21.53% | 273.6K | $209M | $1.37$6.76 |
| BH | Biglari | $245.00 | -$61.74 | -20.13% | 22.5K | $963M | $230.12$483.60 |
| CNSP | Cns Pharmaceuticals | $5.83 | -$1.46 | -20.03% | 125.5K | $5.9M | $1.90$34.80 |
| FABC | StableX Technologies | $3.81 | -$0.76 | -16.68% | 482.4K | $6.7M | $1.64$10.56 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $23.06 | -$4.54 | -16.45% | 678.6K | - | $7.74$41.60 |
| CODX | Co-Diagnostics | $2.15 | -$0.38 | -15.02% | 806.3K | $9.1M | $1.35$46.50 |
| KALA | Kala Bio | $3.37 | -$0.59 | -14.95% | 78.3K | $3.7B | $3.28$1,030.00 |
| MTEX | Mannatech | $4.88 | -$0.82 | -14.39% | 81.4K | $11M | $4.28$12.45 |
| JOUT | Johnson Outdoors | $44.61 | -$6.80 | -13.22% | 40.9K | $532M | $25.53$53.54 |
| RGTZ | Tidal Trust II - Defiance Daily Target 2x Short Rgti ETF | $9.62 | -$1.22 | -11.26% | 3.1M | - | $8.14$37.48 |
| DLLL | GraniteShares ETF Trust - GraniteShares 2x Long Dell Daily ETF | $75.00 | -$8.83 | -10.53% | 348.3K | - | $17.34$86.18 |
| ADVB | Advanced Biomed | $5.58 | -$0.61 | -9.88% | 11.6K | $8.4M | $3.61$25.80 |
| YHGJ | Yunhong Green Cti | $3.23 | -$0.27 | -7.71% | 1.5K | $9.1M | $2.38$10.50 |
| BLIV | BeLive | $2.58 | $0.09 | 3.61% | 194 | $27M | $1.85$5.20 |
Related Articles
Featured Article
Co-Diagnostics: Buy the Dip?
Cory Renauer|Mar 29, 2021
Analysts following this coronavirus stock have darkened their post-pandemic outlook.
What Investors Didn't Like About Co-Diagnostics' Q4 Update
Keith Speights|Mar 26, 2021
The company missed earnings expectations and hinted at slowing growth in 2021.
Co-Diagnostics Names New CFO and CSO
Eric Volkman|Feb 23, 2021
With the latter appointment, the company's founder moves into a more advisory role.
Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?
Taylor Carmichael|Jan 30, 2021
This diagnostic specialist started off the year as a micro cap, but it roared ahead with its COVID-19 test.
Forget Snowflake! Buy This Ultra-High-Growth Stock
Jason Hawthorne|Jan 15, 2021
This business came into 2020 as an unknown, and now it's generating so much growth it makes even high-profile IPOs look like they're standing still.
These Were the 3 Best Coronavirus Stocks of 2020
Keith Speights|Jan 1, 2021
Not all of them were COVID-19 vaccine makers.
These Were the 5 Top Genetics Stocks of 2020
Alex Carchidi|Dec 31, 2020
Investors in fast-moving biotechs made out like bandits.
Up 1,000% in 2020, Is Co-Diagnostics Stock Still a Buy?
Taylor Carmichael|Dec 10, 2020
The company has unbelievable top-line growth right now, and has profit margins over 60%. Will the stock continue to ride high once the world is vaccinated?
3 Reasons It's Not Too Late to Buy Co-Diagnostics
James Halley|Oct 23, 2020
Co-Diagnostics has had a wild run this year. Is it too late to get in on this booming biotech stock?
Is Co-Diagnostics Stock a Buy?
James Halley|Sep 18, 2020
The company's stock had a huge week after announcing that Arches Research has signed a deal to use its coronavirus test kit.
